Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming
Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The...
Ausführliche Beschreibung
Autor*in: |
Bax, Monique [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019transfer abstract |
---|
Übergeordnetes Werk: |
Enthalten in: Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study - Hamood, Rola ELSEVIER, 2018, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:40 ; year:2019 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1016/j.scr.2019.101530 |
---|
Katalog-ID: |
ELV04819090X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV04819090X | ||
003 | DE-627 | ||
005 | 20230626021402.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191023s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.scr.2019.101530 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica |
035 | |a (DE-627)ELV04819090X | ||
035 | |a (ELSEVIER)S1873-5061(19)30160-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.85 |2 bkl | ||
100 | 1 | |a Bax, Monique |e verfasserin |4 aut | |
245 | 1 | 0 | |a Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
264 | 1 | |c 2019transfer abstract | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. | ||
520 | |a Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. | ||
700 | 1 | |a Balez, Rachelle |4 oth | |
700 | 1 | |a Muñoz, Sonia Sanz |4 oth | |
700 | 1 | |a Do-Ha, Dzung |4 oth | |
700 | 1 | |a Stevens, Claire H. |4 oth | |
700 | 1 | |a Berg, Tracey |4 oth | |
700 | 1 | |a Cabral-da-Silva, Mauricio C. |4 oth | |
700 | 1 | |a Engel, Martin |4 oth | |
700 | 1 | |a Nicholson, Garth |4 oth | |
700 | 1 | |a Yang, Shu |4 oth | |
700 | 1 | |a Blair, Ian P. |4 oth | |
700 | 1 | |a Ooi, Lezanne |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Hamood, Rola ELSEVIER |t Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV001654470 |
773 | 1 | 8 | |g volume:40 |g year:2019 |g pages:0 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.scr.2019.101530 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |q VZ |
951 | |a AR | ||
952 | |d 40 |j 2019 |h 0 |
author_variant |
m b mb |
---|---|
matchkey_str |
baxmoniquebalezrachellemuozsoniasanzdoha:2019----:eeainncaatrztooauaidcdlrptnsecllnuw05fodrafbolsseiefoacf61fmlaaytoh |
hierarchy_sort_str |
2019transfer abstract |
bklnumber |
44.85 |
publishDate |
2019 |
allfields |
10.1016/j.scr.2019.101530 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica (DE-627)ELV04819090X (ELSEVIER)S1873-5061(19)30160-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Bax, Monique verfasserin aut Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming 2019transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Balez, Rachelle oth Muñoz, Sonia Sanz oth Do-Ha, Dzung oth Stevens, Claire H. oth Berg, Tracey oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Nicholson, Garth oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:40 year:2019 pages:0 https://doi.org/10.1016/j.scr.2019.101530 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 40 2019 0 |
spelling |
10.1016/j.scr.2019.101530 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica (DE-627)ELV04819090X (ELSEVIER)S1873-5061(19)30160-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Bax, Monique verfasserin aut Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming 2019transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Balez, Rachelle oth Muñoz, Sonia Sanz oth Do-Ha, Dzung oth Stevens, Claire H. oth Berg, Tracey oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Nicholson, Garth oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:40 year:2019 pages:0 https://doi.org/10.1016/j.scr.2019.101530 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 40 2019 0 |
allfields_unstemmed |
10.1016/j.scr.2019.101530 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica (DE-627)ELV04819090X (ELSEVIER)S1873-5061(19)30160-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Bax, Monique verfasserin aut Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming 2019transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Balez, Rachelle oth Muñoz, Sonia Sanz oth Do-Ha, Dzung oth Stevens, Claire H. oth Berg, Tracey oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Nicholson, Garth oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:40 year:2019 pages:0 https://doi.org/10.1016/j.scr.2019.101530 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 40 2019 0 |
allfieldsGer |
10.1016/j.scr.2019.101530 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica (DE-627)ELV04819090X (ELSEVIER)S1873-5061(19)30160-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Bax, Monique verfasserin aut Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming 2019transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Balez, Rachelle oth Muñoz, Sonia Sanz oth Do-Ha, Dzung oth Stevens, Claire H. oth Berg, Tracey oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Nicholson, Garth oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:40 year:2019 pages:0 https://doi.org/10.1016/j.scr.2019.101530 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 40 2019 0 |
allfieldsSound |
10.1016/j.scr.2019.101530 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica (DE-627)ELV04819090X (ELSEVIER)S1873-5061(19)30160-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Bax, Monique verfasserin aut Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming 2019transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. Balez, Rachelle oth Muñoz, Sonia Sanz oth Do-Ha, Dzung oth Stevens, Claire H. oth Berg, Tracey oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Nicholson, Garth oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:40 year:2019 pages:0 https://doi.org/10.1016/j.scr.2019.101530 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 40 2019 0 |
language |
English |
source |
Enthalten in Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study Amsterdam [u.a.] volume:40 year:2019 pages:0 |
sourceStr |
Enthalten in Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study Amsterdam [u.a.] volume:40 year:2019 pages:0 |
format_phy_str_mv |
Article |
bklname |
Kardiologie Angiologie |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
authorswithroles_txt_mv |
Bax, Monique @@aut@@ Balez, Rachelle @@oth@@ Muñoz, Sonia Sanz @@oth@@ Do-Ha, Dzung @@oth@@ Stevens, Claire H. @@oth@@ Berg, Tracey @@oth@@ Cabral-da-Silva, Mauricio C. @@oth@@ Engel, Martin @@oth@@ Nicholson, Garth @@oth@@ Yang, Shu @@oth@@ Blair, Ian P. @@oth@@ Ooi, Lezanne @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV001654470 |
dewey-sort |
3610 |
id |
ELV04819090X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04819090X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626021402.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.scr.2019.101530</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04819090X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1873-5061(19)30160-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bax, Monique</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balez, Rachelle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Muñoz, Sonia Sanz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Do-Ha, Dzung</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stevens, Claire H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berg, Tracey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cabral-da-Silva, Mauricio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engel, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholson, Garth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Shu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blair, Ian P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ooi, Lezanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamood, Rola ELSEVIER</subfield><subfield code="t">Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001654470</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:40</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.scr.2019.101530</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">40</subfield><subfield code="j">2019</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
author |
Bax, Monique |
spellingShingle |
Bax, Monique ddc 610 bkl 44.85 Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
authorStr |
Bax, Monique |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001654470 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.85 bkl Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
topic |
ddc 610 bkl 44.85 |
topic_unstemmed |
ddc 610 bkl 44.85 |
topic_browse |
ddc 610 bkl 44.85 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
r b rb s s m ss ssm d d h ddh c h s ch chs t b tb m c c d mcc mccd m e me g n gn s y sy i p b ip ipb l o lo |
hierarchy_parent_title |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
hierarchy_parent_id |
ELV001654470 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV001654470 |
title |
Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
ctrlnum |
(DE-627)ELV04819090X (ELSEVIER)S1873-5061(19)30160-6 |
title_full |
Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
author_sort |
Bax, Monique |
journal |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
journalStr |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
author_browse |
Bax, Monique |
container_volume |
40 |
class |
610 VZ 44.85 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Bax, Monique |
doi_str_mv |
10.1016/j.scr.2019.101530 |
dewey-full |
610 |
title_sort |
generation and characterization of a human induced pluripotent stem cell line uowi005-a from dermal fibroblasts derived from a ccnf s621g familial amyotrophic lateral sclerosis patient using mrna reprogramming |
title_auth |
Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
abstract |
Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. |
abstractGer |
Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. |
abstract_unstemmed |
Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
url |
https://doi.org/10.1016/j.scr.2019.101530 |
remote_bool |
true |
author2 |
Balez, Rachelle Muñoz, Sonia Sanz Do-Ha, Dzung Stevens, Claire H. Berg, Tracey Cabral-da-Silva, Mauricio C. Engel, Martin Nicholson, Garth Yang, Shu Blair, Ian P. Ooi, Lezanne |
author2Str |
Balez, Rachelle Muñoz, Sonia Sanz Do-Ha, Dzung Stevens, Claire H. Berg, Tracey Cabral-da-Silva, Mauricio C. Engel, Martin Nicholson, Garth Yang, Shu Blair, Ian P. Ooi, Lezanne |
ppnlink |
ELV001654470 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.scr.2019.101530 |
up_date |
2024-07-06T18:10:58.079Z |
_version_ |
1803854238795694080 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04819090X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626021402.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.scr.2019.101530</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001483.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04819090X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1873-5061(19)30160-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bax, Monique</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF S621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNF S621G ), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balez, Rachelle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Muñoz, Sonia Sanz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Do-Ha, Dzung</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stevens, Claire H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berg, Tracey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cabral-da-Silva, Mauricio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engel, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholson, Garth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Shu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blair, Ian P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ooi, Lezanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamood, Rola ELSEVIER</subfield><subfield code="t">Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001654470</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:40</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.scr.2019.101530</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">40</subfield><subfield code="j">2019</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
score |
7.4004726 |